Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CD8+ lymphocyte decrease in HIV disease: association with anti-CD4+ but not with anti-CD8+ lymphocyte autoantibodies

V Daniel1, C Süsal, R Weimer

  • 1Department of Transplantation Immunology, University of Heidelberg, Germany.

Vox Sanguinis
|January 1, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pitfalls in graft survival analysis.

HLA·2017
Same author

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(®) ) in patients with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.

Journal of thrombosis and haemostasis : JTH·2016
Same author

Pre-transplant soluble CD30 in combination with total DSA but not pre-transplant C1q-DSA predicts antibody-mediated graft loss in presensitized high-risk kidney transplant recipients.

HLA·2016
Same author

Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics.

Tissue antigens·2015
Same author

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq<sup>®</sup> ) in adults with severe haemophilia A: efficacy and safety.

Haemophilia : the official journal of the World Federation of Hemophilia·2015

HIV patients develop autoantibodies against CD4+ and CD8+ cells. Anti-CD4+ antibodies correlate with CD8+ cell depletion, suggesting a loss of immune regulation in HIV disease.

Area of Science:

  • Immunology
  • Virology
  • Cell Biology

Background:

  • Autoantibodies against CD4+ and CD8+ lymphocytes are observed in HIV+ patients.
  • Anti-CD4+ autoantibodies are linked to CD4+ cell depletion.
  • CD8+ lymphocyte decrease is common in HIV disease.

Purpose of the Study:

  • To investigate the relationship between anti-CD4+ and anti-CD8+ autoantibodies and CD8+ lymphocyte depletion in HIV disease.
  • To compare the prevalence of these autoantibodies in HIV+ patients versus control groups.

Main Methods:

  • Double fluorescence flow cytometry was used to detect IgM, IgG, and complement fragments on CD4+ and CD8+ lymphocytes.
  • Autoantibody presence was analyzed in HIV+ patients, HIV- individuals, hemophilia patients, pharyngeal carcinoma patients, and individuals with habitual abortions.

Related Experiment Videos

Main Results:

  • Anti-CD8+ autoantibodies were more frequent in HIV+ hemophilia patients compared to various control groups.
  • In HIV+ patients, anti-CD4+ autoantibodies were more prevalent than anti-CD8+ autoantibodies.
  • Peripheral blood CD8+ cell counts were associated with anti-CD4+ autoantibodies, but not anti-CD8+ autoantibodies.

Conclusions:

  • The findings suggest a potential mechanism where anti-CD4+ autoantibodies contribute to CD8+ lymphocyte depletion in HIV disease.
  • This depletion may result from a loss of regulatory functions normally provided by CD4+ cells.
  • Further research is warranted to elucidate the precise role of these autoantibodies in HIV pathogenesis.